nav-left cat-right
cat-right

KINAXO launches KinAffinity® services for efficie...

Martinsried, Germany, October 01, 2009 / b3c newswire / -  KINAXO Biotechnologies GmbH announced today that it added KinAffinity® to its service portfolio. KinAffinity® provides invaluable information about a kinase inhibitor’s selectivity in a cell or tissue of interest. It simultaneously determines affinities for native kinases expressed within a cellular proteome and thus overcomes the limitations of...

Plexxikon Receives Key Patents on Novel Compounds ...

BERKELEY, Calif.–(BUSINESS WIRE)–Plexxikon Inc. today announced the issuance of key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-Based Drug Discoveryâ„¢ platform. Plexxikon’s pipeline of preclinical and clinical stage product opportunities currently span potential treatments for cardio-renal disease, CNS disorders, ...

Thermo Fisher Scientific Accelerates Drug Discover...

Thermo Fisher Scientific, the world leader in serving science, announced recently that it has introduced a novel tool to accelerate hit-to-lead programmes in the drug discovery process. Its Maybridge Quick2Leadâ„¢ Compound Kits are designed to save time and money by enabling rapid compound library synthesis around bioactive “hits” emerging from screening assays. The kits are made up of pre-weighed, diverse...

Plexxikon Receives Key Patents on Novel Compounds ...

BERKELEY, Calif.–(BUSINESS WIRE)–Plexxikon Inc. today announced the issuance of key composition-of-matter patents covering novel compounds discovered through the company’s Scaffold-Based Drug Discoveryâ„¢ platform. Plexxikon’s pipeline of preclinical and clinical stage product opportunities currently span potential treatments for cardio-renal disease, CNS disorders, ...

European Molecular Biology Laboratory (EMBL) Signs...

ST. LOUIS, Mo.–(BUSINESS WIRE)–Triposâ„¢, a leading provider of drug discovery informatics products and services, today announced an agreement with the European Molecular Biology Laboratory (EMBL), Europe’s leading research institution for molecular biology, to license Tripos’ Themisâ„¢ and Surflex-Dockâ„¢ software to support their efforts in Chemical Biology....

ZINC Database – emolecule repository

What is ZINC? It is a free database of millions of commercially-available compounds for virtual screening in ready-to-dock format. Why is it needed? Compounds that are available today can become unavailable in six months because of unavailability of the underlying reagents. For most vendors, the list of available compounds is significantly smaller than the list of compounds they have made in the past. If you are doing...
Page 4 of 15« First...23456...10...Last »